Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for hepatocellular carcinoma: why, when, how?

Miguel R Arguedas1

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, MCLM 281, 1918 University Boulevard, Birmingham, AL 35294, USA. Arguedas@uab.edu

Current Gastroenterology Reports
|January 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxygen desaturation during sleep in hepatopulmonary syndrome.

Hepatology (Baltimore, Md.)·2008
Same author

Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C.

Digestive diseases and sciences·2007
Same author

Utility of pulse oximetry screening for hepatopulmonary syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2007
Same author

Risk of aspiration pneumonia in suspected variceal hemorrhage: the value of prophylactic endotracheal intubation prior to endoscopy.

Digestive diseases and sciences·2007
Same author

Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2007
Same author

Economical and clinical outcomes of alternative treatment strategies in the management of common bile duct stones in the elderly: wait and see or surgery?

The American journal of gastroenterology·2006

Screening for hepatocellular carcinoma (HCC) in cirrhosis patients is recommended but lacks definitive proof of reduced mortality. Further research is needed to establish optimal screening methods and intervals for cost-effectiveness.

Area of Science:

  • Hepatology
  • Oncology
  • Public Health

Background:

  • Hepatocellular carcinoma (HCC) incidence is rising globally, posing a significant public health challenge.
  • Screening for HCC in patients with cirrhosis is recommended to detect early-stage lesions.
  • Current screening practices face controversies regarding efficacy and methodology.

Purpose of the Study:

  • To review the current controversies and unresolved questions in HCC screening.
  • To discuss the impact of these uncertainties on the cost-effectiveness of screening programs.
  • To highlight the need for further research to optimize HCC surveillance strategies.

Main Methods:

  • Review of existing literature on HCC screening and surveillance.
  • Analysis of the impact of screening on disease-specific mortality.

Related Experiment Videos

  • Evaluation of cost-effectiveness considerations for HCC screening programs.

    • Main Results:

    • No randomized controlled trials have confirmed that HCC surveillance reduces disease-specific mortality.
    • The optimal screening test and interval for HCC remain undefined.
    • Some studies suggest potential cost-effectiveness if screening offers even a minor survival benefit.

    Conclusions:

    • Significant questions persist regarding the effectiveness and optimal implementation of HCC screening.
    • Further research, including randomized trials, is crucial to validate screening benefits and define best practices.
    • Clarifying these issues is essential for establishing cost-effective HCC screening programs.